At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NCT06967051N/ARecruitingUpdate OverdueUpdated 11mo ago · Completion was 11mo agoAn Open Label Pilot Study Evaluating the Efficacy of a Smart Phone-based Test on Measuring Pupillary Light Reflex Alterations Following Cannabis Use Healthy in Adults
In Brief
A clinical study evaluating Tetrahydrocannabinol (10 mg), Tetrahydrocannabinol (25 mg), and 2 other interventions for Cannabis Intoxication and Drug Effects. Currently recruiting, targeting 20 participants across 1 site.
Signals
Detailed Summary
The goal of this open label study is to evaluate the efficacy of smart phone-based test (SOBEREYE OPTOVERA) on measuring pupillary light reflex (PLR) alterations following cannabis use healthy in adults. The main question it aims to answer is: Can SOBEREYE OPTOVERA detect PLR alterations following cannabis consumption in healthy adults, in comparison to a pupillometer? Participants will be given two 5 mg capsules to be ingested for the 10 mg THC dose or five 5 mg capsules to be ingested for the 25 mg THC. Participants will be asked to complete PLR tests throughout the study day.
Study Details
Timeline
Interventions
10 mg of Tetrahydrocannabinol (THC) provided as a softgel capsule
25 mg of THC provided as a softgel capsule.
SOBEREYE OPTOVERA is a portable, non-invasive test that measures the Pupillary Light Reflex (PLR)
NeuroLight is an automated pupillometer that generates a flash of light and measures the photomotor reflex very accurately.